Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 3 2Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Genitourinary 1

Conditions

Breast Neoplasms 28Prostatic Neoplasms 14Neoplasm Metastasis 12Osteoporosis 8Multiple Myeloma 8Pain 7Lung Neoplasms 4Fractures, Bone 4Carcinoma, Non-Small-Cell Lung 4Neoplasms, Plasma Cell 3Humoral Hypercalcemia Of Malignancy 3Bone Neoplasms 3Bone Diseases, Metabolic 3Spinal Cord Compression 2Neoplasms 2Lymphoma 2Hematologic Neoplasms 2Triple Negative Breast Neoplasms 1Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Paraproteinemias 1Osteosarcoma 1Neoplastic Processes 1Lymphoma, Non-Hodgkin 1Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1Hematologic Diseases 1Giant Cell Tumor of Bone 1Disease Progression 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Zoledronic Acid × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT00375648 2017-06-02

TRAPEZE

Novartis

Phase 3 Completed
61 enrolled
Genitourinary

Neoplasms, Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡